Vaccine for branhamella catarrhalis
CA 2172728 A1 · Owner: The Research Foundation Of State University Of New York · Inventors: Murphy, Timothy F.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Compositions comprising outer membrane protein "CD" and peptides and oligopeptides thereof of Branhamella catarrhalis are, described. Additionally nucleotide sequences encoding the protein peptide or oligopeptide are disclosed, as well as recombinant vectors containing these sequences. Protein, peptide or oligopeptide can be produced from host cell systems containing these recombinant vectors. Peptides and oligopeptides can also be chemically synthesized. Disclosed are the uses of the protein peptides and oligopeptides as antigens for vaccine formulations, and as antigens in diagnostic immunoassays. The nucleotide sequences are useful for constructing vectors for use as vaccines for …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed September 27, 1994. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended September 27, 2014.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 27, 2016.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.